作为救助策略的"穷人的"左捆分支区域步伐:一个案例系列和一个实用指南的笔驱动LBBAP没有支
Andreas Müssigbrodt1,2, Romain Vergier3, Mickael Cohen3
1Faculty of Medicine, University of Leipzig, 04103, Leipzig, Germany. andreas.muessigbrodt@gmail.com.
概括
左捆支部区域节奏 (LBBAP) 通过产生狭窄的QRS复合体来提供生理心脏节奏. 一种简化的技术,使用传统的,而没有支,在一个小的患者系列中被证明是可行的.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 心脏节拍是因为心脏节拍.
背景情况:
- 左捆分支区域节奏 (LBBAP) 越来越多地被认为是生理节奏替代品.
- 它提供了诸如狭窄的QRS复合体和降低异步心室激活风险等好处.
- 电生理学家的广泛接受强调了它的临床意义.
研究的目的:
- 描述左捆分支区域步调 (LBBAP) 的简化技术.
- 为了证明这种简化的LBBAP技术的可行性,使用传统的笔式驱动引线.
- 为了评估不需要支的方法.
主要方法:
- 为左捆分支区域步调 (LBBAP) 开发了一种简化技术.
- 使用了传统的钢笔驱动的线索.
- 这项手术是在不使用支的情况下进行的.
主要成果:
- 简化的LBBAP技术已经成功演示.
- 在一个由四名患者组成的病例系列中,证明了可行性.
- 该方法允许使用狭窄的QRS复合体进行生理节奏.
结论:
- 对于左捆分支区域节奏 (LBBAP) 的简化技术是可行的.
- 这种方法使用了传统的线索,避免了外套支.
- LBBAP仍然是一个有价值的生理节奏策略.
相关概念视频
Mitral Stenosis III: Medical Management
215
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
215
Dysrhythmias VI: Management of Dysrhythmias
373
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
373
Cardiomyopathy V: Interprofessional Care
305
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
305
Cardiomyopathy II: Dilated Cardiomyopathy
427
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
427
Heart Failure VI: Adjunct Therapies
228
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
228


